BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16:1-24. [PMID: 30171413 DOI: 10.1007/s10388-018-0641-9] [Cited by in Crossref: 138] [Cited by in F6Publishing: 122] [Article Influence: 34.5] [Reference Citation Analysis]
Number Citing Articles
1 Xi K, Chen W, Yu H. The Prognostic Value of Log Odds of Positive Lymph Nodes in Early-Stage Esophageal Cancer Patients: A Study Based on the SEER Database and a Chinese Cohort. J Oncol 2021;2021:8834912. [PMID: 33747080 DOI: 10.1155/2021/8834912] [Reference Citation Analysis]
2 Marginean EC, Dhanpat J. Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues. Ann N Y Acad Sci 2020;1482:130-45. [PMID: 32875588 DOI: 10.1111/nyas.14455] [Reference Citation Analysis]
3 Kuo YH, Fang HY, Lin YS, Lein MY, Yang CY, Ho SC, Li CC, Chien CR. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy. Thorac Cancer 2020;11:113-9. [PMID: 31742897 DOI: 10.1111/1759-7714.13244] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Kaida H, Kitajima K, Nakajo M, Ishibashi M, Matsunaga T, Minamimoto R, Hirata K, Nakatani K, Hung A, Hattori S, Yasuda T, Ishii K. Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan. Eur J Nucl Med Mol Imaging 2021. [PMID: 33934168 DOI: 10.1007/s00259-021-05365-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Matsumoto Y, Fukumitsu N, Ishikawa H, Nakai K, Sakurai H. A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond. J Pers Med 2021;11:825. [PMID: 34442469 DOI: 10.3390/jpm11080825] [Reference Citation Analysis]
6 Saeki H, Sohda M, Sakai M, Sano A, Shirabe K. Role of surgery in multidisciplinary treatment strategies for locally advanced esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2020;4:490-7. [PMID: 33005843 DOI: 10.1002/ags3.12364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yamashita K, Yamamoto K, Takata A, Miyazaki Y, Saito T, Tanaka K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Mano M, Nakajima K, Eguchi H, Doki Y. Continuous ghrelin infusion attenuates the postoperative inflammatory response in patients with esophageal cancer. Esophagus 2021;18:239-47. [PMID: 32856182 DOI: 10.1007/s10388-020-00776-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Shiozaki A, Kudou M, Fujiwara H, Konishi H, Shimizu H, Arita T, Kosuga T, Yamamoto Y, Morimura R, Ikoma H, Kuriu Y, Kubota T, Okamoto K, Otsuji E. Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: Phase I/II study (TNAC). Medicine (Baltimore) 2020;99:e23633. [PMID: 33327342 DOI: 10.1097/MD.0000000000023633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yamauchi T, Fujishima F, Hashimoto M, Tsunokake J, Akaishi R, Gokon Y, Ueki S, Ozawa Y, Fukutomi T, Okamoto H, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes. Cancers (Basel) 2021;13:4473. [PMID: 34503283 DOI: 10.3390/cancers13174473] [Reference Citation Analysis]
10 Shin CM. [Treatment of Superficial Esophageal Cancer: An Update]. Korean J Gastroenterol 2021;78:313-9. [PMID: 34955507 DOI: 10.4166/kjg.2021.155] [Reference Citation Analysis]
11 Ma XL, Gu JY, Qiu JF. Controversy over classifications and surgical approaches for esophagogastric junction carcinomas. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 53-57 [DOI: 10.11569/wcjd.v29.i2.53] [Reference Citation Analysis]
12 Hatta W, Gotoda T, Koike T, Masamune A. Management following endoscopic resection in elderly patients with early-stage upper gastrointestinal neoplasia. Dig Endosc 2020;32:861-73. [PMID: 31802529 DOI: 10.1111/den.13592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kozuki R, Watanabe M, Toihata T, Takahashi K, Otake R, Okamura A, Imamura Y, Mine S. Treatment strategies and outcomes for elderly patients with locally advanced squamous cell carcinoma of the esophagus. Surg Today 2021. [PMID: 34331129 DOI: 10.1007/s00595-021-02348-9] [Reference Citation Analysis]
14 Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Takeuchi H, Watanabe M, Kitagawa Y. Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34142294 DOI: 10.1245/s10434-021-10221-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK. Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer. World J Gastrointest Oncol 2021; 13(11): 1781-1790 [PMID: 34853650 DOI: 10.4251/wjgo.v13.i11.1781] [Reference Citation Analysis]
16 Motoyama S, Maeda E, Iijima K, Anbai A, Sato Y, Wakita A, Nagaki Y, Fujita H, Minamiya Y, Higashi T. Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas. Cancer Sci 2021. [PMID: 34288283 DOI: 10.1111/cas.15070] [Reference Citation Analysis]
17 Shen D, Chen Q, Wu J, Li J, Tao K, Jiang Y. The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma. J Gastrointest Oncol 2021;12:1-10. [PMID: 33708420 DOI: 10.21037/jgo-20-599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Moreno MCF, Law S. Surgical Protocols for Squamous Cell Cancer of the Esophagus. Methods Mol Biol 2020;2129:335-58. [PMID: 32056189 DOI: 10.1007/978-1-0716-0377-2_25] [Reference Citation Analysis]
19 Matsueda K, Ishihara R. Preoperative Diagnosis and Indications for Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma. J Clin Med 2020;10:E13. [PMID: 33374639 DOI: 10.3390/jcm10010013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Onishi S, Tajika M, Tanaka T, Yamada K, Abe T, Higaki E, Hosoi T, Inaba Y, Muro K, Shimizu M, Niwa Y. Prognostic Impact of Sarcopenic Obesity after Neoadjuvant Chemotherapy Followed by Surgery in Elderly Patients with Esophageal Squamous Cell Carcinoma. J Clin Med 2020;9:E2974. [PMID: 32942595 DOI: 10.3390/jcm9092974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
21 Bang CS, Lee JJ, Baik GH. Computer-aided diagnosis of esophageal cancer and neoplasms in endoscopic images: a systematic review and meta-analysis of diagnostic test accuracy. Gastrointest Endosc 2021;93:1006-1015.e13. [PMID: 33290771 DOI: 10.1016/j.gie.2020.11.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
22 Nakagawa K, Ishihara R, Aoyama K, Ohmori M, Nakahira H, Matsuura N, Shichijo S, Nishida T, Yamada T, Yamaguchi S, Ogiyama H, Egawa S, Kishida O, Tada T. Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists. Gastrointest Endosc. 2019;90:407-414. [PMID: 31077698 DOI: 10.1016/j.gie.2019.04.245] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 17.3] [Reference Citation Analysis]
23 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Toh Y, Inoue Y, Hayakawa M, Yamaki C, Takeuchi H, Ohira M, Matsubara H, Doki Y, Wakao F, Takayama T. Creation and provision of a question and answer resource for esophageal cancer based on medical professionals' reports of patients' and families' views and preferences. Esophagus 2021;18:872-9. [PMID: 34169363 DOI: 10.1007/s10388-021-00857-7] [Reference Citation Analysis]
25 Haneda R, Kikuchi H, Nagakura Y, Notsu A, Booka E, Murakami T, Matsumoto T, Mayanagi S, Morita Y, Hiramatsu Y, Tsubosa Y, Takeuchi H. Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter, Retrospective Study. Ann Surg Oncol 2022. [PMID: 35235087 DOI: 10.1245/s10434-022-11491-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Barbieri L, Talavera Urquijo E, Parise P, Nilsson M, Reynolds JV, Rosati R. Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Dis Esophagus 2020;33:doaa028. [PMID: 32322892 DOI: 10.1093/dote/doaa028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
27 Yin Z, Yang R, Jiang Y, Chen Q, Cai H. Perioperative Clinical Results of Transcervical and Transhiatal Esophagectomy versus Thoracoscopic Esophagectomy in Patients with Esophageal Carcinoma: A Prospective, Randomized, Controlled Study. IJGM 2022;Volume 15:3393-404. [DOI: 10.2147/ijgm.s347230] [Reference Citation Analysis]
28 Booka E, Haneda R, Ishii K, Tsushima T, Yasui H, Tsubosa Y. The Negative Impact of Preoperative Chemotherapy on Survival After Esophagectomy for Vulnerable Elderly Patients with Esophageal Cancer. Ann Surg Oncol 2021;28:1786-95. [PMID: 32876790 DOI: 10.1245/s10434-020-09072-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kato K, Ito Y, Nozaki I, Daiko H, Kojima T, Yano M, Ueno M, Nakagawa S, Takagi M, Tsunoda S, Abe T, Nakamura T, Okada M, Toh Y, Shibuya Y, Yamamoto S, Katayama H, Nakamura K, Kitagawa Y; Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology 2021:S0016-5085(21)03352-7. [PMID: 34389340 DOI: 10.1053/j.gastro.2021.08.007] [Reference Citation Analysis]
30 Booka E, Haneda R, Ishii K, Kawakami T, Tsushima T, Yasui H, Onoe T, Ogawa H, Tsubosa Y. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020;27:3163-3170. [PMID: 32314159 DOI: 10.1245/s10434-020-08440-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
31 Zhang CD, Takeshima H, Sekine S, Yamashita S, Liu YY, Hattori N, Abe H, Yamashita H, Fukuda M, Imamura Y, Ushiku T, Katai H, Makino H, Watanabe M, Seto Y, Ushijima T. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation. Gastric Cancer 2021. [PMID: 34557982 DOI: 10.1007/s10120-021-01252-y] [Reference Citation Analysis]
32 Yeh JH, Huang RY, Lee CT, Lin CW, Hsu MH, Wu TC, Hsiao PJ, Wang WL. Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: a systematic review and meta-analysis. Therap Adv Gastroenterol 2020;13:1756284820964316. [PMID: 33224272 DOI: 10.1177/1756284820964316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fujiwara D, Watanabe M, Kanie Y, Maruyama S, Sakamoto K, Okamura A, Kanamori J, Imamura Y, Mine S. Is Prophylactic Cervical Drainage Effective in Patients Undergoing McKeown Esophagectomy Reconstructed Through the Retrosternal Route with Two-Field Lymphadenectomy? World J Surg 2022. [PMID: 35445357 DOI: 10.1007/s00268-022-06578-x] [Reference Citation Analysis]
34 Nishizawa T, Suzuki H. Long-Term Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E2849. [PMID: 33023117 DOI: 10.3390/cancers12102849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Haneda R, Hiramatsu Y, Kawata S, Honke J, Soneda W, Matsumoto T, Morita Y, Kikuchi H, Kamiya K, Takeuchi H. Survival impact of perioperative changes in prognostic nutritional index levels after esophagectomy. Esophagus 2021. [PMID: 34546503 DOI: 10.1007/s10388-021-00883-5] [Reference Citation Analysis]
36 Kurita D, Oguma J, Ishiyama K, Hirano Y, Kanamori J, Daiko H. Handgrip Strength Predicts Postoperative Pneumonia After Thoracoscopic–Laparoscopic Esophagectomy for Patients with Esophageal Cancer. Ann Surg Oncol 2020;27:3173-81. [DOI: 10.1245/s10434-020-08520-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Hamamoto Y, Murakami K, Kato K, Kitagawa Y. Management of elderly patients with esophageal squamous cell cancer. Jpn J Clin Oncol 2022:hyac067. [PMID: 35511482 DOI: 10.1093/jjco/hyac067] [Reference Citation Analysis]
38 Tang H, Jiang D, Zhang S, Zeng Z, Tan L, Hou Y, Wang Q, Wang H, Zhu J, Shen Y, Yin J, Ge D; Zhongshan NCRT-EC working group. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2020:S0022-5223(20)32634-9. [PMID: 33268125 DOI: 10.1016/j.jtcvs.2020.09.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Miyawaki Y, Sato H, Lee S, Fujita S, Oya S, Sugita H, Hirano Y, Okamoto K, Koyama I, Sakuramoto S. Impact of the coronavirus disease 2019 pandemic on first-visit patients with oesophageal cancer in the first infection wave in Saitama prefecture near Tokyo: a single-centre retrospective study. Jpn J Clin Oncol 2022:hyac002. [PMID: 35079828 DOI: 10.1093/jjco/hyac002] [Reference Citation Analysis]
40 Izutsu M, Domoto T, Kamoshida S, Ohsaki H, Matsuoka H, Umeki Y, Shiogama K, Hirayama M, Suda K, Uyama I. Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma. World J Surg Oncol 2022;20:105. [PMID: 35365176 DOI: 10.1186/s12957-022-02571-9] [Reference Citation Analysis]
41 Watanabe M, Otake R, Kozuki R, Toihata T, Takahashi K, Okamura A, Imamura Y. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today 2020;50:12-20. [PMID: 31535225 DOI: 10.1007/s00595-019-01878-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 13.3] [Reference Citation Analysis]
42 Suzuki T, Furukawa K, Funasaka K, Ishikawa E, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Miyahara R, Fujishiro M. Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection. Digestion 2021;102:563-71. [PMID: 32894837 DOI: 10.1159/000510091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Visaggi P, Barberio B, Ghisa M, Ribolsi M, Savarino V, Fassan M, Valmasoni M, Marchi S, de Bortoli N, Savarino E. Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence. Cancers (Basel) 2021;13:3162. [PMID: 34202763 DOI: 10.3390/cancers13133162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Yamamoto Y, Uedo N. Management of adverse events related to endoscopic resection of esophageal and gastric neoplasms: Report of consensus meeting. Digestive Endoscopy 2019;31:2-3. [DOI: 10.1111/den.13386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Akaishi R, Fujishima F, Ishida H, Tsunokake J, Yamauchi T, Gokon Y, Ueki S, Fukutomi T, Okamoto H, Takaya K, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma. Esophagus 2022. [PMID: 34999996 DOI: 10.1007/s10388-021-00904-3] [Reference Citation Analysis]
46 Haneda R, Booka E, Ishii K, Kikuchi H, Hiramatsu Y, Kamiya K, Ogawa H, Yasui H, Takeuchi H, Tsubosa Y. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma. World J Surg 2021;45:1835-44. [PMID: 33620541 DOI: 10.1007/s00268-021-06016-4] [Reference Citation Analysis]
47 Muro K, Kojima T, Moriwaki T, Kato K, Nagashima F, Kawakami H, Ishihara R, Ogata T, Satoh T, Iwakami K, Han S, Yatsuzuka N, Takami T, Bhagia P, Doi T. Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181. Esophagus 2021. [PMID: 34591237 DOI: 10.1007/s10388-021-00877-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yagi K, Toriumi T, Aikou S, Yamashita H, Seto Y. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:436-45. [PMID: 34337292 DOI: 10.1002/ags3.12448] [Reference Citation Analysis]
49 Eyck BM, van Lanschot JJB, Hulshof MCCM, van der Wilk BJ, Shapiro J, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar Bilgen EJ, van der Sangen MJC, Rozema T, Ten Kate FJW, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A; CROSS Study Group. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial. J Clin Oncol 2021;39:1995-2004. [PMID: 33891478 DOI: 10.1200/JCO.20.03614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
50 Esaki M, Horii T, Ichijima R, Wada M, Sakisaka S, Abe S, Tomoeda N, Kitagawa Y, Nishioka K, Minoda Y, Tsuruta S, Suzuki S, Akiho H, Ihara E, Ogawa Y, Gotoda T. Assistant skill in gastric endoscopic submucosal dissection using a clutch cutter. World J Gastrointest Surg 2021; 13(2): 116-126 [PMID: 33643532 DOI: 10.4240/wjgs.v13.i2.116] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chen H, Chen I, Chen Y, Chen C, Chuang C, Lin C. The Influence of Socioeconomic Status on Esophageal Cancer in Taiwan: A Population-Based Study. JPM 2022;12:595. [DOI: 10.3390/jpm12040595] [Reference Citation Analysis]
52 Kagami T, Yamade M, Suzuki T, Uotani T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Baba S, Sugimura H, Murai J, Pommier Y, Furuta T. The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy. BMC Cancer 2020;20:1123. [PMID: 33218331 DOI: 10.1186/s12885-020-07574-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Maruyama S, Kawaguchi Y, Akaike H, Shoda K, Saito R, Shimizu H, Furuya S, Hosomura N, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D. Postoperative Complications have Minimal Impact on Long-Term Prognosis in Immunodeficient Patients with Esophageal Cancer. Ann Surg Oncol 2020;27:3064-70. [PMID: 32048090 DOI: 10.1245/s10434-020-08245-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Xie C, Jing Z, Luo H, Jiang W, Ma L, Hu W, Zheng A, Li D, Ding L, Zhang H, Xie C, Lian X, Du D, Chen M, Bian X, Tan B, Xia B, Xie R, Liu Q, Wang L, Wu S. Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial. Br J Cancer 2020;123:1616-24. [PMID: 32958820 DOI: 10.1038/s41416-020-01054-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
55 Kanie Y, Okamura A, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33839977 DOI: 10.1245/s10434-021-09945-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Booka E, Takeuchi H, Kitagawa Y. Esophageal Cancer Practice Guidelines in Japan. In: Ando N, editor. Esophageal Squamous Cell Carcinoma. Singapore: Springer; 2020. pp. 131-47. [DOI: 10.1007/978-981-15-4190-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Wei MT, Friedland S. Early Esophageal Cancer: What the Gastroenterologist Needs to Know. Gastroenterol Clin North Am 2021;50:791-808. [PMID: 34717871 DOI: 10.1016/j.gtc.2021.07.004] [Reference Citation Analysis]
58 Ito M, Yajima S, Suzuki T, Oshima Y, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Tochigi N, Shimada H. High serum PD-L1 level is a poor prognostic biomarker in surgically treated esophageal cancer. Cancer Med 2020;9:1321-7. [PMID: 31865635 DOI: 10.1002/cam4.2789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
59 Fujimoto D, Taniguchi K, Takashima J, Miura F, Kobayashi H. Double tract-like gastric tube reconstruction decreases the incidences of delayed gastric emptying and bile reflux after esophagectomy: results of a pilot study of an experimental technique. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02461-4] [Reference Citation Analysis]
60 Sun HB, Xing WQ, Liu XB, Zheng Y, Yang SJ, Wang ZF, Liu SL, Ba YF, Zhang RX, Liu BX, Fan CC, Chen PN, Liang GH, Yu YK, Liu Q, Wang HR, Li HM, Li ZX; written on Henan Cancer Hospital Thoracic Oncology Group (HCHTOG). Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a single-Centre, open-label, randomized, controlled, clinical trial (HCHTOG1903). BMC Cancer 2020;20:303. [PMID: 32293362 DOI: 10.1186/s12885-020-06824-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
61 Mahawongkajit P, Boochangkool N. Comparison of Preoperative CT Colonography and Colonoscopy for Esophageal Reconstruction with Colonic Interposition. Surg Res Pract 2020;2020:6585762. [PMID: 33283041 DOI: 10.1155/2020/6585762] [Reference Citation Analysis]
62 Iwatsubo T, Ishihara R, Yamasaki Y, Tonai Y, Hamada K, Kato M, Suzuki S, Kono M, Fukuda H, Shimamoto Y, Nakagawa K, Ohmori M, Arao M, Matsuno K, Iwagami H, Inoue S, Nakahira H, Matsuura N, Shichijo S, Maekawa A, Kanesaka T, Takeuchi Y, Higashino K, Uedo N, Higuchi K. Narrow band imaging under less-air condition improves the visibility of superficial esophageal squamous cell carcinoma. BMC Gastroenterol 2020;20:389. [PMID: 33213383 DOI: 10.1186/s12876-020-01534-2] [Reference Citation Analysis]
63 Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirasawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc 2021. [PMID: 34599604 DOI: 10.1111/den.14154] [Reference Citation Analysis]
64 Okamura A, Hayami M, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma. Esophagus. 2020;17:59-66. [PMID: 31595397 DOI: 10.1007/s10388-019-00700-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
65 Booka E, Kikuchi H, Hiramatsu Y, Takeuchi H. The Impact of Infectious Complications after Esophagectomy for Esophageal Cancer on Cancer Prognosis and Treatment Strategy. J Clin Med 2021;10:4614. [PMID: 34640631 DOI: 10.3390/jcm10194614] [Reference Citation Analysis]
66 Kouzu K, Tsujimoto H, Ishibashi Y, Shinada H, Oikawa I, Kishi Y, Shinomiya N, Ueno H. Preoperative Fall Risk Assessment Score as a Prognostic Factor in Esophageal Cancer Patients after Esophagectomy. J Clin Med 2021;10:5966. [PMID: 34945262 DOI: 10.3390/jcm10245966] [Reference Citation Analysis]
67 Tu DH, Qu R, Wang Q, Fu X. After-hours esophagectomy may pose additional risk to patients with esophageal cancer. J Thorac Dis 2021;13:1118-29. [PMID: 33717585 DOI: 10.21037/jtd-20-3141] [Reference Citation Analysis]
68 Motoyama S, Sato Y, Wakita A, Nagaki Y, Fujita H, Sasamori R, Kemuriyama K, Takashima S, Imai K, Minamiya Y. Lower local recurrence rate after robot-assisted thoracoscopic esophagectomy than conventional thoracoscopic surgery for esophageal cancer. Sci Rep 2021;11:6774. [PMID: 33762693 DOI: 10.1038/s41598-021-86420-x] [Reference Citation Analysis]
69 Murakami K, Yoshida M, Uesato M, Toyozumi T, Isozaki T, Urahama R, Kano M, Matsumoto Y, Matsubara H. Does thoracoscopic esophagectomy really reduce post-operative pneumonia in all cases? Esophagus 2021;18:724-33. [PMID: 34247287 DOI: 10.1007/s10388-021-00855-9] [Reference Citation Analysis]
70 Fujita H. Ways and tradition of Japan in esophageal surgery for cancer. Gen Thorac Cardiovasc Surg 2020;68:1187-92. [DOI: 10.1007/s11748-020-01369-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Harada K, Rogers JE, Iwatsuki M, Yamashita K, Baba H, Ajani JA. Recent advances in treating oesophageal cancer. F1000Res 2020;9:F1000 Faculty Rev-1189. [PMID: 33042518 DOI: 10.12688/f1000research.22926.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Hiraki Y, Kimura Y, Imano M, Kato H, Iwama M, Shiraishi O, Yasuda A, Shinkai M, Makino T, Motoori M, Yamasaki M, Miyata H, Satou T, Satoh T, Furukawa H, Yano M, Doki Y, Yasuda T. Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma. Surg Today 2021;51:118-26. [PMID: 32596796 DOI: 10.1007/s00595-020-02059-7] [Reference Citation Analysis]
73 Zhang SW, Zhang N, Wang N. Role of COL3A1 and POSTN on Pathologic Stages of Esophageal Cancer. Technol Cancer Res Treat 2020;19:1533033820977489. [PMID: 33280513 DOI: 10.1177/1533033820977489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Tanaka T, Ueno M, Iizuka T, Hoteya S, Haruta S, Udagawa H. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Dis Esophagus 2019;32:doz023. [PMID: 30980070 DOI: 10.1093/dote/doz023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Tajiri A, Ishihara R, Sakurai H, Nakamura T, Tani Y, Inoue T, Matsueda K, Miyake M, Waki K, Fukuda H, Shichijo S, Maekawa A, Kanesaka T, Yamamoto S, Takeuchi Y, Higashino K, Uedo N, Michida T, Kitamura M, Honma K. Positive predictive value of the clinical diagnosis of T1a-epithelial/lamina propria esophageal cancer depends on lesion size. Dig Endosc 2021. [PMID: 34601748 DOI: 10.1111/den.14153] [Reference Citation Analysis]
76 Toh Y, Numasaki H, Tachimori Y, Uno T, Jingu K, Nemoto K, Matsubara H. Current status of radiotherapy for patients with thoracic esophageal cancer in Japan, based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society. Esophagus 2020;17:25-32. [DOI: 10.1007/s10388-019-00690-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zhang SM, Wang YJ, Zhang ST. Accuracy of artificial intelligence-assisted detection of esophageal cancer and neoplasms on endoscopic images: A systematic review and meta-analysis. J Dig Dis 2021;22:318-28. [PMID: 33871932 DOI: 10.1111/1751-2980.12992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Kobayashi K, Kanetaka K, Yoneda A, Kobayashi S, Maruya Y, Isagawa Y, Yoshimoto T, Migita K, Kawaguchi Y, Kuba S, Morita M, Okada S, Kosaka T, Yamaguchi S, Inoue Y, Adachi T, Hidaka M, Torashima Y, Ito S, Takatsuki M, Eguchi S. Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute Experience. J Gastrointest Cancer 2021;52:582-92. [PMID: 32524305 DOI: 10.1007/s12029-020-00431-x] [Reference Citation Analysis]
79 Omori A, Tsunoda S, Nishigori T, Hisamori S, Hoshino N, Ikeda A, Obama K. Clinical Benefits of Routine Feeding Jejunostomy Tube Placement in Patients Undergoing Esophagectomy. J Gastrointest Surg 2022. [PMID: 35141836 DOI: 10.1007/s11605-022-05265-5] [Reference Citation Analysis]
80 Toriumi T, Yagi K, Ri M, Yajima S, Okumura Y, Aikou S, Yamashita H, Nomura S, Seto Y. Lymphatic invasion is a prognostic factor of pathological N0 esophageal squamous cell carcinoma. Dis Esophagus 2021:doab087. [PMID: 34937084 DOI: 10.1093/dote/doab087] [Reference Citation Analysis]
81 Ikawa T, Ishihara R, Matsueda K, Konishi K, Yamamoto S, Morimoto M, Kanayama N, Teshima T. Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study. BMC Cancer 2022;22:301. [PMID: 35313853 DOI: 10.1186/s12885-022-09418-2] [Reference Citation Analysis]
82 Hirahara N, Matsubara T, Fujii Y, Kaji S, Hyakudomi R, Yamamoto T, Uchida Y, Miyazaki Y, Ishitobi K, Kawabata Y, Tajima Y. Geriatric nutritional risk index as a prognostic marker of pTNM-stage I and II esophageal squamous cell carcinoma after curative resection. Oncotarget 2020;11:2834-46. [PMID: 32754301 DOI: 10.18632/oncotarget.27670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Shimizu D, Koike M, Kanda M, Sonohara F, Hattori N, Hayashi M, Tanaka C, Yamada S, Kodera Y. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus. Surg Today 2021;51:153-8. [PMID: 32638131 DOI: 10.1007/s00595-020-02072-w] [Reference Citation Analysis]
84 Oh D, Kim JH. The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Korean J Thorac Cardiovasc Surg 2020;53:160-7. [PMID: 32793446 DOI: 10.5090/kjtcs.2020.53.4.160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Suzuki T, Okamura A, Watanabe M, Mine S, Imamura Y, Asari T, Osumi H, Nakayama I, Ichimura T, Ogura M, Ooki A, Takahari D, Yamaguchi K, Chin K. Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:1510-7. [DOI: 10.1245/s10434-019-08124-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Jin C, Qi H, Xu Y, Li S. Serine 727 phosphorylation is necessary to induce the STAT3-mediated transcription of LINC00184 in oesophageal squamous cell carcinoma. Mol Cell Biochem. [DOI: 10.1007/s11010-022-04405-4] [Reference Citation Analysis]
87 Yamauchi K, Iwamuro M, Nakagawa M, Takenaka R, Matsueda K, Inaba T, Yoshioka M, Toyokawa T, Tanaka S, Kanzaki H, Kawano S, Kawahara Y, Shirakawa Y, Okada H; Okayama Gut Study Group. Long-term outcomes of endoscopic versus surgical resection for MM-SM1 esophageal squamous cell carcinoma using propensity score analysis. Esophagus 2021;18:72-80. [PMID: 32876825 DOI: 10.1007/s10388-020-00775-0] [Reference Citation Analysis]
88 Kanda M, Koike M, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Kodera Y. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Ann Surg Oncol 2020;27:3195-205. [PMID: 32246314 DOI: 10.1245/s10434-020-08433-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
89 Kakeji Y, Oshikiri T, Takiguchi G, Kanaji S, Matsuda T, Nakamura T, Suzuki S. Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy. Esophagus. 2021;18:25-32. [PMID: 32964312 DOI: 10.1007/s10388-020-00782-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
90 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy 2022. [PMID: 35523224 DOI: 10.1055/a-1811-7025] [Reference Citation Analysis]
91 Tang N, Feng Z. Endoscopic submucosal dissection combined with adjuvant chemotherapy for early-stage neuroendocrine carcinoma of the esophagus: A case report. World J Clin Cases 2022; 10(10): 3164-3169 [DOI: 10.12998/wjcc.v10.i10.3164] [Reference Citation Analysis]
92 Matsumoto S, Wakatsuki K, Nakade H, Kunishige T, Miyao S, Tsujimoto A, Tatsumi T, Sho M. Impact of CT-assessed changes in tumor size after neoadjuvant chemotherapy on pathological response and survival of patients with esophageal squamous cell carcinoma. Langenbecks Arch Surg 2022. [PMID: 34989856 DOI: 10.1007/s00423-022-02430-x] [Reference Citation Analysis]
93 Fujihara S, Kobara H, Nishiyama N, Hirose K, Iwama H, Masaki T. MicroRNA Expression Profiles in Superficial Esophageal Squamous Cell Carcinoma before Endoscopic Submucosal Dissection: A Pilot Study. Int J Mol Sci 2021;22:4789. [PMID: 33946439 DOI: 10.3390/ijms22094789] [Reference Citation Analysis]
94 Imamura H, Tamura S, Hattori H, Kidogami S, Mokutani Y, Kishimoto T, Hashimoto Y, Hirose H, Yoshioka S, Kuwayama M, Endo S, Sasaki Y. Coexisting primary tumors from esophageal cancer and myelodysplastic syndromes: A case report. Clin Case Rep 2021;9:e04872. [PMID: 34584722 DOI: 10.1002/ccr3.4872] [Reference Citation Analysis]
95 Sun Y, Wang J, Ma Y, Li J, Sun X, Zhao X, Shi X, Hu Y, Qu F, Zhang X. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p. J Exp Clin Cancer Res 2021;40:306. [PMID: 34587992 DOI: 10.1186/s13046-021-02084-5] [Reference Citation Analysis]
96 Kamada T, Ohdaira H, Takeuchi H, Takahashi J, Marukuchi R, Ito E, Suzuki N, Narihiro S, Hoshimoto S, Yoshida M, Urashima M, Suzuki Y. Vertical distance from navel as a risk factor for bowel obstruction associated with feeding jejunostomy after esophagectomy: a retrospective cohort study. BMC Gastroenterol 2020;20:354. [PMID: 33109092 DOI: 10.1186/s12876-020-01506-6] [Reference Citation Analysis]
97 Triantafyllou T, Wijnhoven BPL. Current status of esophageal cancer treatment. Chin J Cancer Res 2020;32:271-86. [PMID: 32694894 DOI: 10.21147/j.issn.1000-9604.2020.03.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Yago A, Ohkura Y, Ueno M, Fujisawa K, Ogawa Y, Shimoyama H, Urabe M, Haruta S, Udagawa H. Identification of Preoperative Fat-Free Mass Index for the Prognosis of Curatively Resected Esophageal Cancer. World J Surg 2022. [PMID: 34985544 DOI: 10.1007/s00268-021-06435-3] [Reference Citation Analysis]
99 Suzuki T, Okamura A, Watanabe M, Chin K. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma? Ann Surg Oncol 2020;27:1518-9. [PMID: 32108921 DOI: 10.1245/s10434-020-08282-3] [Reference Citation Analysis]
100 Shimamoto Y, Ishihara R, Kato Y, Shoji A, Inoue T, Matsueda K, Miyake M, Waki K, Kono M, Fukuda H, Matsuura N, Nagaike K, Aoi K, Yamamoto K, Nakahara M, Nishihara A, Tada T. Real-time assessment of video images for esophageal squamous cell carcinoma invasion depth using artificial intelligence. J Gastroenterol. 2020;55:1037-1045. [PMID: 32778959 DOI: 10.1007/s00535-020-01716-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
101 Yu X, Zhang R, Yang T, Zhang M, Xi K, Lin Y, Wen Y, Wang G, Huang Z, Zhang X, Zhang L. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. J Thorac Dis 2019;11:3980-90. [PMID: 31656672 DOI: 10.21037/jtd.2019.08.92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
102 Imamura H, Hirose H, Endo S, Hashimoto Y, Takeda M, Kidogami S, Mokutani Y, Kishimoto T, Yoshioka S, Tamura S, Sasaki Y. Simultaneous triple cancer of the esophagus, pancreas and rectum treated with multimodal strategies: a case report. Surg Case Rep 2020;6:259. [PMID: 33006693 DOI: 10.1186/s40792-020-01035-0] [Reference Citation Analysis]
103 Deng W, Jethwa KR, Gonuguntla K, Liao Z, Yoon HH, Murphy MB, Haddock MG, Hallemeier CL, Lin SH. Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma. Adv Radiat Oncol 2020;5:951-8. [PMID: 33083658 DOI: 10.1016/j.adro.2020.03.020] [Reference Citation Analysis]
104 Esaki M, Haraguchi K, Akahoshi K, Tomoeda N, Aso A, Itaba S, Ogino H, Kitagawa Y, Fujii H, Nakamura K, Kubokawa M, Harada N, Minoda Y, Suzuki S, Ihara E, Ogawa Y. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12(8): 918-930 [PMID: 32879668 DOI: 10.4251/wjgo.v12.i8.918] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
105 Kadota T, Yoda Y, Hori K, Shinmura K, Oono Y, Ikematsu H, Yano T. Prophylactic steroid administration against strictures is not enough for mucosal defects involving the entire circumference of the esophageal lumen after esophageal endoscopic submucosal dissection (ESD). Esophagus 2020;17:440-7. [PMID: 32172461 DOI: 10.1007/s10388-020-00730-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
106 Wada Y, Anbai A, Takagi N, Kumagai S, Okuyama E, Nanjo H, Sato Y, Motoyama S, Hashimoto M. Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study. Cancers (Basel) 2020;13:E8. [PMID: 33375169 DOI: 10.3390/cancers13010008] [Reference Citation Analysis]
107 Hölscher AH, Law S. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers. Gastric Cancer 2020;23:3-9. [DOI: 10.1007/s10120-019-01022-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
108 Miyawaki Y, Sato H, Fujiwara N, Oya S, Sugita H, Hirano Y, Yamane T, Sakuramoto S, Okamoto K, Yamaguchi S, Koyama I. Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study. Int J Clin Oncol 2020;25:561-9. [PMID: 31867680 DOI: 10.1007/s10147-019-01606-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Chang JW, Jung DH, Huh CW, Park JC, Shin SK, Lee SK, Lee YC. Long-Term Outcomes and Prognostic Factors of Superficial Esophageal Cancer in Patients Aged ≥ 65 Years. Front Med 2022;8:722141. [DOI: 10.3389/fmed.2021.722141] [Reference Citation Analysis]
110 Wang AY, Hwang JH, Bhatt A, Draganov PV. AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary. Gastroenterology 2021;161:2030-2040.e1. [PMID: 34689964 DOI: 10.1053/j.gastro.2021.08.058] [Reference Citation Analysis]
111 Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Kumagai K, Watanabe M. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg 2022. [PMID: 35420308 DOI: 10.1007/s00423-022-02508-6] [Reference Citation Analysis]
112 Booka E, Haneda R, Ishii K, Tsubosa Y. ASO Author Reflections: The Impact of Preoperative Chemotherapy on Survival After Esophagectomy in Elderly Patients with Esophageal Cancer. Ann Surg Oncol 2021;28:1796-7. [PMID: 32860173 DOI: 10.1245/s10434-020-09078-1] [Reference Citation Analysis]
113 Waters JK, Reznik SI. Update on Management of Squamous Cell Esophageal Cancer. Curr Oncol Rep 2022. [PMID: 35142974 DOI: 10.1007/s11912-021-01153-4] [Reference Citation Analysis]
114 Sato H, Miyawaki Y, Lee S, Sugita H, Sakuramoto S, Tsubosa Y. Effectiveness and safety of a newly introduced multidisciplinary perioperative enhanced recovery after surgery protocol for thoracic esophageal cancer surgery. Gen Thorac Cardiovasc Surg 2021. [PMID: 34596825 DOI: 10.1007/s11748-021-01717-y] [Reference Citation Analysis]
115 Motoyama S, Maeda E, Yano M, Yasuda T, Ohira M, Kajiyama Y, Higashi T, Doki Y, Matsubara H. Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching. Esophagus 2020;17:141-8. [PMID: 31939000 DOI: 10.1007/s10388-019-00712-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Taniyama Y, Murakami K, Yoshida N, Takahashi K, Matsubara H, Baba H, Kamei T. Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study. BMC Cancer 2021;21:1008. [PMID: 34496769 DOI: 10.1186/s12885-021-08747-y] [Reference Citation Analysis]
117 Namikawa K, Yoshio T, Yoshimizu S, Ishiyama A, Tsuchida T, Tokai Y, Horiuchi Y, Hirasawa T, Fujisaki J. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma. Sci Rep 2021;11:6554. [PMID: 33753766 DOI: 10.1038/s41598-021-85572-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer 2021. [PMID: 34675397 DOI: 10.1038/s41416-021-01485-9] [Reference Citation Analysis]
119 Yang X, Men Y, Wang J, Kang J, Sun X, Zhao M, Sun S, Yuan M, Bao Y, Ma Z, Wang G, Hui Z. Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study. Technol Cancer Res Treat 2021;20:15330338211048051. [PMID: 34657505 DOI: 10.1177/15330338211048051] [Reference Citation Analysis]
120 Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(46): 6767-6780 [PMID: 31857778 DOI: 10.3748/wjg.v25.i46.6767] [Reference Citation Analysis]
121 Yu X, Gao S, Xue Q, Tan F, Gao Y, Mao Y, Wang D, Zhao J, Li Y, He J, Mu J. Development of a predictive nomogram for cause-specific mortality in surgically resected early-stage oesophageal cancer: a Surveillance, Epidemiology, and End Results (SEER) analysis. J Thorac Dis 2020;12:2583-94. [PMID: 32642166 DOI: 10.21037/jtd.2020.03.25] [Reference Citation Analysis]
122 Miyawaki Y, Sato H, Oya S, Sugita H, Hirano Y, Sakuramoto S, Okamotom K, Yamaguchim S, Koyama I. Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study. BMC Cancer 2021;21:725. [PMID: 34162359 DOI: 10.1186/s12885-021-08484-2] [Reference Citation Analysis]
123 Chen Z, Dou L, Liu Y, Zhang Y, He S, Xue L, Wang G. Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions. Front Oncol 2021;11:786015. [PMID: 34900740 DOI: 10.3389/fonc.2021.786015] [Reference Citation Analysis]
124 Kim GH, Jung HY. Endoscopic Resection for the Treatment of Superficial Esophageal Neoplasms. Korean J Thorac Cardiovasc Surg 2020;53:172-7. [PMID: 32793448 DOI: 10.5090/kjtcs.2020.53.4.172] [Reference Citation Analysis]
125 Akaishi R, Fujishima F, Ishida H, Tsunokake J, Yamauchi T, Gokon Y, Ueki S, Fukutomi T, Okamoto H, Takaya K, Sato C, Taniyama Y, Nakamura T, Nakaya N, Kamei T, Sasano H. HO-1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy. Cancer Rep (Hoboken) 2021;:e1477. [PMID: 34264023 DOI: 10.1002/cnr2.1477] [Reference Citation Analysis]
126 Lee HD, Chung H, Kwak Y, Choi J, Lee A, Kim JL, Cho SJ, Kim SG. Endoscopic Submucosal Dissection Versus Surgery for Superficial Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Survival Analysis. Clin Transl Gastroenterol 2020;11:e00193. [PMID: 32675704 DOI: 10.14309/ctg.0000000000000193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Liu W, Yuan X, Guo L, Pan F, Wu C, Sun Z, Tian F, Yuan C, Zhang W, Bai S, Feng J, Hu Y, Hu B. Artificial Intelligence for Detecting and Delineating Margins of Early ESCC Under WLI Endoscopy. Clin Transl Gastroenterol 2022;13:e00433. [PMID: 35130184 DOI: 10.14309/ctg.0000000000000433] [Reference Citation Analysis]
128 Kotani S, Shibagaki K, Yuki T, Aimi M, Mikami H, Izumi D, Yamashita N, Takahashi Y, Fukuba N, Ishimura N, Ishihara S. A multicenter retrospective study of the esophageal triamcinolone acetonide-filling method in patients with extensive esophageal endoscopic submucosal dissection. Scand J Gastroenterol 2021;56:647-55. [PMID: 33856943 DOI: 10.1080/00365521.2021.1910998] [Reference Citation Analysis]
129 Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: Towards targeted therapies. Cell Oncol (Dordr) 2020;43:195-209. [PMID: 31848929 DOI: 10.1007/s13402-019-00488-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
130 Sumiya T, Ishikawa H, Hiroshima Y, Nakamura M, Murakami M, Mizumoto M, Okumura T, Sakurai H. The impact of lymphopenia during chemoradiotherapy using photons or protons on the clinical outcomes of esophageal cancer patients. J Radiat Res 2021:rrab094. [PMID: 34632514 DOI: 10.1093/jrr/rrab094] [Reference Citation Analysis]
131 Kimura H, Yoshida M, Yabuuchi Y, Kakushima N, Yamamoto Y, Kawata N, Takizawa K, Kishida Y, Imai K, Ito S, Hotta K, Ishiwatari H, Matsubayashi H, Ono H. Long-term outcomes of salvage endoscopic submucosal dissection for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Jpn J Clin Oncol 2021;51:1036-43. [PMID: 33758950 DOI: 10.1093/jjco/hyab027] [Reference Citation Analysis]
132 Takahashi K, Nishikawa K, Tanishima Y, Ishikawa Y, Kobayashi T, Masuda T, Kurogochi T, Yuda M, Tanaka Y, Matsumoto A, Yano F, Eto K. Risk stratification of anastomotic stricture using early postoperative endoscopic and computed tomography findings in patients undergoing esophagectomy with cervical esophagogastric anastomosis for esophageal cancer. Dis Esophagus 2022:doac004. [PMID: 35178563 DOI: 10.1093/dote/doac004] [Reference Citation Analysis]
133 Booka E, Tsubosa Y, Yokota T, Mayanagi S, Ishii K, Urakami K, Ohshima K, Ohnami S, Nagashima T, Yamaguchi K. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA. Esophagus 2021;18:743-52. [PMID: 33826001 DOI: 10.1007/s10388-021-00835-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Matsuda S, Kawakubo H, Irino T, Kitagawa Y. Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer. Jpn J Clin Oncol 2021:hyab192. [PMID: 34891170 DOI: 10.1093/jjco/hyab192] [Reference Citation Analysis]
135 Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020;13:1010-21. [PMID: 32965635 DOI: 10.1007/s12328-020-01237-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
136 Mahawongkajit P, Techagumpuch A, Limpavitayaporn P, Kanlerd A, Sriussadaporn E, Juntong J, Tongyoo A, Mingmalairak C. Comparison of Introducer Percutaneous Endoscopic Gastrostomy with Open Gastrostomy in Advanced Esophageal Cancer Patients. Dysphagia 2020;35:117-20. [PMID: 31025103 DOI: 10.1007/s00455-019-10017-w] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
137 Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:1209-16. [PMID: 32524457 DOI: 10.1245/s10434-020-08716-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
138 Kurumi H, Onoyama T, Isomoto H. How to manage esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic resection. J Gastroenterol 2021. [PMID: 34350486 DOI: 10.1007/s00535-021-01816-w] [Reference Citation Analysis]
139 Inokuchi Y, Watanabe M, Hayashi K, Kaneta Y, Furuta M, Machida N, Maeda S. Feasibility, efficacy, and cautionary note of endoscopic resection for gastric tube cancer after esophagectomy. Surg Endosc. [DOI: 10.1007/s00464-022-09240-8] [Reference Citation Analysis]
140 Takahashi M, Takahashi K, Muguruma K, Ohira M, Nagayama K. Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer. Int J Clin Oncol 2021. [PMID: 34686932 DOI: 10.1007/s10147-021-02057-w] [Reference Citation Analysis]
141 Schlosser T, Hoffmeister A, Feisthammel J, Niebisch S, Thieme R, Gockel I. [Treatment recommendations for early esophageal cancer : Endoscopic and surgical options]. Chirurg 2021;92:1077-84. [PMID: 34622303 DOI: 10.1007/s00104-021-01513-7] [Reference Citation Analysis]
142 Wang S, Pan D, Chen Z, Song G, Han R, Sun G, Su M. Trends in Incidence and Mortality of Esophageal Cancer in Huai'an District, a High-Risk Area in Northern Jiangsu Province, China. Cancer Control 2022;29:10732748221076824. [PMID: 35196897 DOI: 10.1177/10732748221076824] [Reference Citation Analysis]
143 Zhang Y, Liu L, Wang Q, Guo L, Ye L, Zeng H, Zeng X, Yuan X, Li Y, Zhang Y, Zhou E, Hu B. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial. Endoscopy 2020;52:1066-74. [PMID: 32668474 DOI: 10.1055/a-1198-5232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
144 Guo D, Zheng K. Effect of Prophylactic Radiotherapy on Patients with Stage II-III Esophageal Cancer after Esophageal Cancer Radical Operation and Influencing Factors in Its Recurrence. J Oncol 2021;2021:7462012. [PMID: 34462636 DOI: 10.1155/2021/7462012] [Reference Citation Analysis]
145 Rocha-Filho DR, Peixoto RD, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Di Paula Filho RP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Ribeiro U Jr, Jesus VHF, Costa WL Jr, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer. Ecancermedicalscience 2021;15:1195. [PMID: 33889204 DOI: 10.3332/ecancer.2021.1195] [Reference Citation Analysis]
146 Thakur B, Devkota M, Chaudhary M. Management of Locally Advanced Esophageal Cancer. JNMA J Nepal Med Assoc 2021;59:409-16. [PMID: 34508544 DOI: 10.31729/jnma.4299] [Reference Citation Analysis]
147 Miyazaki T, Myojin M, Hosokawa M, Aoyama H, Okahara S, Takahashi H. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study. Radiat Oncol 2022;17. [DOI: 10.1186/s13014-021-01972-6] [Reference Citation Analysis]
148 Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Li SY, Iwadate Y, Yamagata H, Jambaljav B, Takemoto M, Yokote K, Takizawa H, Shimada H. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Front Oncol 2021;11:708039. [PMID: 34504788 DOI: 10.3389/fonc.2021.708039] [Reference Citation Analysis]
149 Harada K, Zhao M, Baba H, Ajani JA. Endoscopic resection for esophageal or gastroesophageal junction adenocarcinoma. Dig Med Res 2019;2:7. [PMID: 31179442 DOI: 10.21037/dmr.2019.04.01] [Reference Citation Analysis]
150 Zhao X, Huang Q, Koller M, Linssen MD, Hooghiemstra WTR, de Jongh SJ, van Vugt MATM, Fehrmann RSN, Li E, Nagengast WB. Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy. Int J Mol Sci 2021;22:9270. [PMID: 34502178 DOI: 10.3390/ijms22179270] [Reference Citation Analysis]
151 Yura M, Koyanagi K, Hara A, Hayashi K, Tajima Y, Kaneko Y, Fujisaki H, Hirata A, Takano K, Hongo K, Yo K, Yoneyama K, Tamai Y, Dehari R, Nakagawa M. Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report. World J Clin Cases 2021; 9(12): 2801-2810 [PMID: 33969062 DOI: 10.12998/wjcc.v9.i12.2801] [Reference Citation Analysis]
152 Tang H, Tan L, Wang H, Shen Y, Yin J. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved. J Gastrointest Surg 2020;24:1469-76. [DOI: 10.1007/s11605-019-04317-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
153 Taketa T, Uchiyama Y, Kodama N, Koyama T, Domen K. Rehabilitation Management for a Patient with Bilateral Pneumothorax after Surgery for Esophageal Cancer. PRM 2022;7:n/a. [DOI: 10.2490/prm.20220017] [Reference Citation Analysis]
154 Liao XY, Liu CY, He JF, Wang LS, Zhang T. Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy. Oncol Lett 2019;18:5011-21. [PMID: 31612012 DOI: 10.3892/ol.2019.10893] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
155 Ueki S, Fujishima F, Kumagai T, Ishida H, Okamoto H, Takaya K, Sato C, Taniyma Y, Kamei T, Sasano H. GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy. BMC Cancer 2020;20:161. [PMID: 32106831 DOI: 10.1186/s12885-020-6652-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
156 Yu M, Tan Y, Liu D. Strategies to prevent stricture after esophageal endoscopic submucosal dissection. Ann Transl Med 2019;7:271. [PMID: 31355238 DOI: 10.21037/atm.2019.05.45] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
157 Yamamoto S, Kawakami H, Kii T, Hara H, Kawabata R, Kawada J, Takeno A, Matsuyama J, Ueda S, Okita Y, Endo S, Kimura Y, Yanagihara K, Okuno T, Kurokawa Y, Shimokawa T, Satoh T. Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. Eur J Cancer 2021;154:307-15. [PMID: 34311300 DOI: 10.1016/j.ejca.2021.06.035] [Reference Citation Analysis]
158 Yano T. Can endoscopic submucosal dissection be an appropriate initial treatment for T1 esophageal squamous cell carcinoma? Dig Endosc 2022. [PMID: 35486023 DOI: 10.1111/den.14285] [Reference Citation Analysis]
159 Shinozaki H, Matsuoka T, Ozawa S. Pharmacological treatment to reduce pulmonary morbidity after esophagectomy. Ann Gastroenterol Surg 2021;5:614-22. [PMID: 34585046 DOI: 10.1002/ags3.12469] [Reference Citation Analysis]
160 Ozawa S. What is an appropriate strategy of conversion surgery for cT4b thoracic esophageal cancer? Ann Gastroenterol Surg 2021;5:130-1. [PMID: 33860133 DOI: 10.1002/ags3.12453] [Reference Citation Analysis]
161 Hayashi M, Abe M, Fujita T, Matsushita H. Assessing the Prognostic Value of Extranodal Extension in Esophageal Cancer from the Pathological Staging Perspective. J Invest Surg 2021;:1-9. [PMID: 34096439 DOI: 10.1080/08941939.2021.1912221] [Reference Citation Analysis]
162 Fan M, Dai L, Yan W, Yang Y, Lin Y, Chen K. Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer. Thorac Cancer 2021;12:2182-8. [PMID: 34137505 DOI: 10.1111/1759-7714.14054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
163 Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y. Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE). Jpn J Clin Oncol 2019;49:1055-60. [PMID: 31411696 DOI: 10.1093/jjco/hyz112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
164 Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020;32:452-93. [PMID: 32072683 DOI: 10.1111/den.13654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
165 Triantafyllou T, Olson MT, Theodorou D, Zografos G, Singhal S. Esophageal cancer: challenges, concerns, and recommendations for management amidst the COVID-19 pandemic. Ann Gastroenterol 2020;33:453-8. [PMID: 32879590 DOI: 10.20524/aog.2020.0519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Jung MK, Schmidt T, Chon SH, Chevallay M, Berlth F, Akiyama J, Gutschow CA, Mönig SP. Current surgical treatment standards for esophageal and esophagogastric junction cancer.Ann N Y Acad Sci. 2020;1482:77-84. [PMID: 32798235 DOI: 10.1111/nyas.14454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
167 Takahashi M, Kato K, Okada M, Chin K, Kadowaki S, Hamamoto Y, Doki Y, Kubota Y, Kawakami H, Ogata T, Hara H, Muto M, Nakashima Y, Ishihara R, Tsuda M, Motoyama S, Kodani M, Kitagawa Y. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus 2021;18:90-9. [PMID: 33170461 DOI: 10.1007/s10388-020-00794-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Kawashima K, Abe S, Koga M, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Hikichi T, Ohira H, Saito Y. Optimal selection of endoscopic resection in patients with esophageal squamous cell carcinoma: endoscopic mucosal resection versus endoscopic submucosal dissection according to lesion size. Diseases of the Esophagus 2021;34:doaa096. [DOI: 10.1093/dote/doaa096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]